Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vβ Gene Expansion

Forty-two patients with cutaneous T-cell lymphoma, including 31 with exfoliative erythroderma or Sezary syndrome and 11 with mycosis fungoides, were studied for the occurrence of staphylococcal infection. Thirty-two of 42 (76%) had a positive staphylococcal culture from skin or blood. One half of the patients with positive cultures grew Staphylococcus aureus. This group included 11 with Sezary syndrome and 5 with rapidly enlarging mycosis fungoides plaques or tumors. All of the S aureus carried enterotoxin genes. Surprisingly, 6 of 16 strains were the same toxic shock toxin-1 (TSST-1)-positive clone, designated electrophoretic type (ET)-41. Analysis of the T-cell receptor Vβ repertoire in 14 CTCL patients found that only 4 had the expected monoclonal expansion of a specific Vβ gene, whereas 10 had oligoclonal or polyclonal expansion of several Vβ families. All patients with TSST-1+ S aureus had overexpansion of Vβ 2 in blood and/or skin lesions. These studies show that S aureus containing superantigen enterotoxins are commonly found in patients with CTCL, especially individuals with erythroderma where they could exacerbate and/or perpetuate stimulate chronic T-cell expansion and cutaneous inflammation. Attention to toxigenic S aureus in CTCL patients would be expected to improve the quality of care and outcome of this patient population.

[1]  D. Leung,et al.  A potential role for superantigens in the pathogenesis of psoriasis. , 1993, The Journal of investigative dermatology.

[2]  W. Noble,et al.  Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. , 1983, Journal of medical microbiology.

[3]  K. Asadullah,et al.  Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. , 1996, The Journal of investigative dermatology.

[4]  P. Marrack,et al.  Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.

[5]  Y. Tokura,et al.  Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. , 1992, The Journal of investigative dermatology.

[6]  G. Wood,et al.  Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment , 1993, CA: a cancer journal for clinicians.

[7]  H. Koh,et al.  Sézary syndrome: diagnosis, prognosis, and critical review of treatment options. , 1990, Journal of the American Academy of Dermatology.

[8]  P. Marrack,et al.  The staphylococcal enterotoxins and their relatives. , 1990, Science.

[9]  Haralampos J. Milionis,et al.  Cutaneous T-cell lymphoma. , 2005, The Journal of dermatologic surgery and oncology.

[10]  P. E. Shapiro,et al.  The Histologic Spectrum of Mycosis Fungoides/Sézary Syndrome (Cutaneous T‐Cell Lymphoma): A Review of 222 Biopsies, Including Newly Described Patterns and the Earliest Pathologic Changes , 1994, The American journal of surgical pathology.

[11]  R. Edelson,et al.  Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. , 1994, Archives of dermatology.

[12]  S. Walker,et al.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. , 1993, The Journal of clinical investigation.

[13]  P. Schlievert,et al.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome , 1993, The Lancet.

[14]  P. Marrack,et al.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Noordijk,et al.  Cutaneous T‐cell lymphoma: clinicopathological relationships, therapy and survival in ninety‐two patients , 1982, The British journal of dermatology.

[16]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[17]  M. Duvic,et al.  Photopheresis therapy for cutaneous T-cell lymphoma. , 1996, Journal of the American Academy of Dermatology.

[18]  D. Carlo,et al.  CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Duvic Staphylococcal infections and the pruritus of AIDS-related complex. , 1987, Archives of dermatology.

[20]  C. Janeway Are There Cellular Superantigens? , 1993, Immunological reviews.

[21]  S. Rosenberg,et al.  Dermatologic changes associated with interleukin 2 administration. , 1987, JAMA.

[22]  E. Coutavas,et al.  The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. , 1995, The Journal of clinical investigation.

[23]  R. Warnke,et al.  Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. , 1992, The American journal of pathology.

[24]  H. Mcdevitt,et al.  Autoimmune diseases: the failure of self tolerance. , 1990, Science.

[25]  A. Jack,et al.  Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region genes. , 1990, The American journal of pathology.

[26]  D. Carlo,et al.  Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Duvic,et al.  Emergence of leprosy in a patient with mycosis fungoides. , 1994, Journal of the American Academy of Dermatology.

[28]  J. Mcfadden,et al.  Superantigenic exotoxin‐secreting potential of staphylococci isolated from atopic eczematous skin , 1993, The British journal of dermatology.

[29]  F. Sigaux,et al.  Expression of Vβ Gene Segments by Sezary Cells , 1995 .

[30]  S. Tyler,et al.  Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction , 1991, Journal of clinical microbiology.

[31]  J. Musser,et al.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. , 1993, The Journal of clinical investigation.

[32]  Don C. Wiley,et al.  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.

[33]  G. Rovera,et al.  Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangements. , 1991, The Journal of investigative dermatology.

[34]  B. Jegasothy,et al.  Cutaneous T-cell lymphoma: utility of antibodies to the variable regions of the human T-cell antigen receptor. , 1992, Journal of the American Academy of Dermatology.

[35]  B. Fleischer,et al.  Major histocompatibility complex class II‐associated peptides determine the binding of the superantigen toxic shock syndrome toxin‐1 , 1995, European journal of immunology.

[36]  T. Kohsaka,et al.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Ahmed,et al.  Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. , 1975, Annals of internal medicine.

[38]  B. Safai,et al.  Association of HLA-DR5 with mycosis fungoides. , 1983, The Journal of investigative dermatology.

[39]  M. Delmée,et al.  Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR , 1995, Journal of clinical microbiology.

[40]  R. Cook,et al.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. , 1989, Science.

[41]  H. Schrezenmeier,et al.  T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures. , 1989, Cellular immunology.

[42]  J. Musser,et al.  Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination , 1992, Journal of clinical microbiology.

[43]  M. Duvic,et al.  Cutaneous T-cell lymphoma after blood transfusion , 1993, The Lancet.

[44]  K. Smith,et al.  Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis. , 1994, Archives of dermatology.

[45]  A. Deisseroth,et al.  Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? , 1995, Blood.

[46]  R. Sékaly,et al.  T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens , 1994, The Journal of experimental medicine.

[47]  L. Steinman,et al.  Characterization of T‐Cell Receptor αβ Repertoire in Synovial Tissue from Different Temporal Phases of Rheumatoid Arthritis , 1992 .

[48]  L. Skov,et al.  Superantigens. Do they have a role in skin diseases? , 1995, Archives of dermatology.

[49]  X. Yan,et al.  Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A‐binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells , 1992, Clinical and experimental immunology.

[50]  Y. Tokura,et al.  Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens , 1995, The British journal of dermatology.

[51]  R. Klausner,et al.  The T‐Cell Antigen Receptor , 1988, Annals of the New York Academy of Sciences.

[52]  R. Balderas,et al.  Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome. , 1992, The American journal of pathology.

[53]  A. Menter,et al.  Cutaneous T-cell lymphoma in association with silicone breast implants. , 1995, Journal of the American Academy of Dermatology.

[54]  T. Whittam,et al.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics , 1986, Applied and environmental microbiology.

[55]  M. Duvic,et al.  HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. , 1996, The Journal of investigative dermatology.

[56]  S. Malka,et al.  Mycosis fungoides—a disease of antigen persistence , 1974, The British journal of dermatology.

[57]  M. Duvic,et al.  Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. , 1987, Archives of dermatology.

[58]  R. Warnke,et al.  Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. , 1993, The Journal of investigative dermatology.

[59]  G. Clayman,et al.  Keratinocyte transglutaminase expression varies in squamous cell carcinomas. , 1994, The Journal of investigative dermatology.

[60]  C. Berger,et al.  Malignant and normal T cells show random use of T-cell receptor alpha chain variable regions in patients with cutaneous T-cell lymphoma. , 1995, The Journal of investigative dermatology.

[61]  H. Sampson,et al.  Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.

[62]  M. Bigby,et al.  T-cell receptor V beta expression in normal human skin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Cook,et al.  Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. , 1991, Journal of immunology.